A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine

A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine

The research and development (R&D) of novel adjuvants is an effective measure for improving the immunogenicity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant protein vaccine. Toward this end, we designed a novel single-stranded RNA-based adjuvant, L2, from the SA...

Full description

Bibliographic Details
Main Authors: Dong Liu, Chaoqiang An, Yu Bai, Kelei Li, Jianyang Liu, Qian Wang, Qian He, Ziyang Song, Jialu Zhang, Lifang Song, Bopei Cui, Qunying Mao, Wei Jiang, Zhenglun Liang
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
single-stranded RNA-based adjuvant
immune response
SARS-CoV-2 recombinant protein vaccine
Online Access:https://www.mdpi.com/1999-4915/14/9/1854

Internet

https://www.mdpi.com/1999-4915/14/9/1854

Similar Items